New Key Statistics Module, Z-Score and F-Score
NYSE:RMD Key Ratios
Market Cap $ M | 31,436.67 |
Enterprise Value $ M | 32,366.21 |
P/E(ttm) | 32.87 |
PE Ratio without NRI | 29.52 |
Forward PE Ratio | 26.21 |
Price/Book | 6.79 |
Price/Sales | 6.89 |
Price/Free Cash Flow | 29.46 |
Price/Owner Earnings | 31.63 |
Payout Ratio % | 0.26 |
Revenue (TTM) $ M | 4,584.00 |
EPS (TTM) $ | 6.51 |
Beneish M-Score | -2.41 |
10-y EBITDA Growth Rate % | 11.70 |
5-y EBITDA Growth Rate % | 15.20 |
y-y EBITDA Growth Rate % | 14.80 |
EV-to-EBIT | 25.11 |
EV-to-EBITDA | 21.49 |
PEG | 1.94 |
Shares Outstanding M | 146.91 |
Net Margin (%) | 20.91 |
Operating Margin % | 28.12 |
Pre-tax Margin (%) | 25.83 |
Quick Ratio | 1.97 |
Current Ratio | 3.04 |
ROA % (ttm) | 14.12 |
ROE % (ttm) | 22.37 |
ROIC % (ttm) | 17.46 |
Dividend Yield % | 0.89 |
Altman Z-Score | 11.16 |
RMD Number of Guru Trades
RMD Volume of Guru Trades
Gurus Latest Trades with NYSE:RMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:RMD is held by these investors
Total 2
ResMed Inc Insider Transactions
No Available Data
News about NYSE:RMD
Total 0- 1